Edwards Lifesciences Corporation (EW) Q2 2024 Earnings Results

Edwards Lifesciences Beats on EPS, Stock Down 0.11%

Edwards Lifesciences reported an EPS of $0.70, beating expectations slightly. However, the stock reacted negatively, declining by 0.11%. The lack of revenue information and management commentary may have contributed to investor uncertainty.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.70	N/A	+0.57%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

Edwards Lifesciences Beats on EPS, Stock Down 0.11%

Key numbers

Management commentary

Edwards Lifesciences Corporation

More earnings this week

Edwards Lifesciences Beats on EPS, Stock Down 0.11%

Key numbers

Management commentary